Sanofi-Aventis
Istanbul, Turkey (Türkiye)
NCT Number: NCT00272532
Study objective:
* To demonstrate, in patients with myofascial pain syndrome in cervical region, the degree of efficacy of thiocolchicoside ointment administered to trigger point regions compared with the trigger point injection.
Looking for future studies?
Notify Me18 year–50 year
All sexes
Interventional
Phase 4
Istanbul, Turkey (Türkiye)
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Sanofi
Industry
The Efficacy of Topical Thiocolchicoside in Cervical Myofascial Pain Syndrome: Triple-Arm, Single-Blind, Randomized, Prospective, Phase IV Clinical Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07515352
Muscular Diseases, Musculoskeletal Diseases
Kannur, Kerala, India
View Trial DetailsNCT07410221
Agnosia, Anxiety Disorders
Istanbul, Merkez, Turkey (Türkiye)
View Trial DetailsNCT02436096
Connective Tissue Diseases, Fibromyalgia
Birmingham, Alabama, United States
View Trial DetailsNCT06768281
Muscular Diseases, Musculoskeletal Diseases
Istanbul, Fatih, Turkey (Türkiye)
View Trial Details